Expert Interview
Looking at the impact of GLP-1 weight loss medications on the Continuous Glucose Monitoring (CGM) Market in Type 2 Diabetes
Ticker(s): DXCM, SENS, ABT, MDT, LLY, NVOInstitution: NYU Langone Health
- Clinical Assistant Professor of Medicine at NYU Grossman School of Medicine
- Manages over 300 patients a month with type 2 diabetes and obesity
- Research interest in weight loss maintenance and obesity medicine
Please describe your background and patient setting
Added By: ben_adminHow many patients do you manage who utilize a CGM device? # with T2D?
Added By: ben_adminWhat are the most popular CGM devices used today?
Added By: ben_adminHave GLP1 medications decreased your T2D populations usage of CGMs?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
